94-3554. Listing of Color Additives Subject to Certification; FD&C Blue No. 1  

  • [Federal Register Volume 59, Number 32 (Wednesday, February 16, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-3554]
    
    
    [[Page Unknown]]
    
    [Federal Register: February 16, 1994]
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    21 CFR Part 74
    
    [Docket No. 92C-0295]
    
     
    
    Listing of Color Additives Subject to Certification; FD&C Blue 
    No. 1
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the color 
    additive regulations to provide for the safe use of FD&C Blue No. 1 and 
    FD&C Blue No. 1 Aluminum Lake for coloring drugs and cosmetics intended 
    for use in the area of the eye. This action is in response to a 
    petition filed by the Cosmetic, Toiletry, and Fragrance Association 
    (CTFA).
    
    DATES: Effective February 17, 1994, except as to any provisions that 
    may be stayed by the filing of proper objections; written objections 
    and requests for a hearing by March 18, 1994.
    
    ADDRESSES: Submit written objections to the Dockets Management Branch 
    (HFA-305), Food and Drug Administration, rm. 1-23, 12420 Parklawn Dr., 
    Rockville, MD 20857.
    
    FOR FURTHER INFORMATION CONTACT: Robert L. Martin, Center for Food 
    Safety and Applied Nutrition (HFS-217), Food and Drug Administration, 
    200 C St. SW. Washington, DC 20204, 202-254-9519.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Introduction
    
        In a notice published in the Federal Register of August 11, 1992 
    (57 FR 35833), FDA announced that a color additive petition (CAP 
    6C0206) had been filed by CTFA, 1101 17th St. NW., suite 300, 
    Washington, DC 20036. The petition proposed that the color additive 
    regulations for FD&C Blue No. 1 be amended to provide for the safe use 
    of FD&C Blue No. 1 and its lakes for coloring drugs and cosmetics 
    intended for use in the area of the eye. The petition was filed under 
    section 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
    379e). CTFA later amended the petition to limit the lakes requested for 
    eye area use to FD&C Blue No. 1 Aluminum Lake prepared in accordance 
    with Sec. 82.51 (21 CFR 82.51).
    
    II. Definitions
    
        Section 70.3(s) (21 CFR 70.3(s)) defines the term ``area of the 
    eye'' as ``the area enclosed within the circumference of the supra-
    orbital ridge and the infra-orbital ridge, including the eyebrow, the 
    skin below the eyebrow, the eyelids and the eyelashes, and conjunctival 
    sac of the eye, the eyeball, and the soft areolar tissue that lies 
    within the perimeter of the infra-orbital ridge.'' The term ``lake'' is 
    defined in Sec. 70.3(l) as ``straight color extended on a substratum by 
    adsorption, coprecipitation, or chemical combination that does not 
    include any combination of ingredients made by simple mixing process.''
    
    III. Background
    
        Section 70.5(a) (21 CFR 70.5(a)) states that ``No listing or 
    certification of a color additive shall be considered to authorize the 
    use of any such color additive in any article intended for use in the 
    area of the eye unless such listing or certification of such color 
    additive specifically provides for such use.'' The regulations, in 
    Sec. 81.1 (21 CFR 81.1), state that the color additive lakes listed 
    therein may not be used in products that are intended to be used in the 
    area of the eye. The petitioner has requested that the uses for FD&C 
    Blue No. 1 and FD&C Blue No. 1 Aluminum Lake be expanded to include 
    uses in the area of the eye.
        Part 82 (21 CFR part 82) lists the certified provisionally listed 
    colors and specifications and includes a description of, and 
    specifications for, the lakes that are permitted for use in foods 
    (Sec. 82.51) and in drugs and cosmetics (Sec. 82.1051). Sections 82.51 
    and 82.1051 list the acceptable lakes that can be combined with the 
    straight colors listed therein. The petitioner has requested that this 
    order be limited to the Aluminum Lake of FD&C Blue No. 1, prepared in 
    accordance with Sec. 82.51. Section 82.51 also limits the substrata 
    that can be used for FD&C lakes to alumina.
    
    IV. Safety
    
        In its evaluation of the safety of the proposed use of the subject 
    color additive, FDA has considered the safety data submitted previously 
    to support current listings for the use of FD&C Blue No. 1 in foods, 
    drugs, and cosmetics. FDA also evaluated ocular toxicity studies 
    submitted to support eye area use of the color additive and its 
    aluminum lake. FDA has determined that the petitioned use is safe, 
    because no adverse effects were found in these studies at levels 
    relevant to the petitioned use.
    
    V. Conclusions
    
        Based on data contained in the petition and other relevant 
    material, FDA concludes that there is a reasonable certainty that no 
    harm will result from the use of FD&C Blue No. 1 and FD&C Blue No. 1 
    Aluminum Lake as color additives in the area of the eye, and that the 
    additives are safe for their intended use. The agency also concludes on 
    the basis of available data that the color additive will perform its 
    intended effect and thus is suitable for the petitioned uses. The 
    agency, therefore, is amending the color additive regulations in 
    Secs. 74.1101(c) and 74.2101(c) (21 CFR 74.1101(c) and 74.2101(c)) to 
    provide for the use of FD&C Blue No. 1 and FD&C Blue No. 1 Aluminum 
    Lake in drugs and cosmetics, respectively, intended for use in the area 
    of the eye.
        This document provides for the permanent listing of the aluminum 
    lake of FD&C Blue No. 1 for use in the area of the eye. Other uses of 
    the lakes of FD&C Blue No. 1 are provisionally listed under Secs. 81.1, 
    82.51, 82.101, and 82.1051. The agency notes that Secs. 74.1101(b)(2) 
    and 74.2101(b)(2) refer to Secs. 82.51 and 82.1051 for the 
    manufacturing process and specifications for the lakes of FD&C Blue No. 
    1. While the agency recognizes that this referral is to a section that 
    is designated as provisional, FDA considers this referral to be 
    appropriate because that section defines current good manufacturing 
    practice and provides appropriate specifications to ensure the quality 
    and purity of lakes made with the color additive. The agency has under 
    consideration an action to permanently list all lakes that have been 
    provisionally listed under parts 81 and 82. When that action is 
    completed, FDA intends to amend this referral as appropriate.
    
    VI. Inspection of Documents
    
        In accordance with Sec. 71.15 (21 CFR 71.15), the petition and the 
    documents that FDA considered and relied upon in reaching its decision 
    to list the petitioned uses are available for inspection at the Center 
    for Food Safety and Applied Nutrition (address above) by appointment 
    with the information contact person listed above. As provided in 
    Sec. 71.15, the agency will delete from the documents any materials 
    that are not available for public disclosure before making the 
    documents available for inspection.
    
    VII. Environmental Impact
    
        The agency has carefully considered the potential environmental 
    effects of this action. FDA has concluded that the action will not have 
    a significant impact on the human environment, and that an 
    environmental impact statement is not required. The agency's finding of 
    no significant impact and the evidence supporting that finding, 
    contained in an environmental assessment, may be seen in the Dockets 
    Management Branch (address above) between 9 a.m. and 4 p.m., Monday 
    through Friday.
    
    VIII. Objections
    
        Any person who will be adversely affected by this regulation may at 
    any time on or before March 18, 1994, file with the Dockets Management 
    Branch (address above) written objections thereto. Each objection shall 
    be separately numbered, and each numbered objection shall specify with 
    particularity the provisions of the regulation to which objection is 
    made and the grounds for the objection. Each numbered objection on 
    which a hearing is requested shall specifically so state. Failure to 
    request a hearing for any particular objection shall constitute a 
    waiver of the right to a hearing on that objection. Each numbered 
    objection for which a hearing is requested shall include a detailed 
    description and analysis of the specific factual information intended 
    to be presented in support of the objection in the event that a hearing 
    is held. Failure to include such a description and analysis for any 
    particular objection shall constitute a waiver of the right to a 
    hearing on the objection. Three copies of all documents shall be 
    submitted and shall be identified with the docket number found in 
    brackets in the heading of this document. Any objections received in 
    response to the regulation may be seen in the Dockets Management Branch 
    between 9 a.m. and 4 p.m., Monday through Friday. FDA will publish 
    notice of the objections that the agency has received or lack thereof 
    in the Federal Register.
    
    List of Subjects in 21 CFR Part 74
    
        Color additives, Cosmetics, Drugs.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    74 is amended as follows:
    
    PART 74--LISTING OF COLOR ADDITIVES SUBJECT TO CERTIFICATION
    
        1. The authority citation for 21 CFR part 74 continues to read as 
    follows:
        Authority: Secs. 201, 401, 402, 403, 409, 501, 502, 505, 601, 
    602, 701, 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
    321, 341, 342, 343, 348, 351, 352, 355, 361, 362, 371, 379e).
        2. Section 74.1101 is amended by revising paragraphs (b) and (c) to 
    read as follows:
    
    Sec. 74.1101  FD&C Blue No. 1.
    
    * * * * *
        (b) Specifications. (1) The color additive FD&C Blue No. 1 for use 
    in coloring drugs generally shall conform in specifications to the 
    requirements of Sec. 74.101(b).
        (2) FD&C Blue No. 1 Aluminum Lake shall be prepared in accordance 
    with the requirements of Sec. 82.51 of this chapter.
        (c) Uses and restrictions. (1) FD&C Blue No. 1 may be safely used 
    for coloring drugs, including drugs intended for use in the area of the 
    eye, in amounts consistent with current good manufacturing practice.
        (2) FD&C Blue No. 1 Aluminum Lake may be safely used for coloring 
    drugs intended for use in the area of the eye, in amounts consistent 
    with current good manufacturing practice, subject to the restrictions 
    on the use of color additives in Sec. 70.5(b) and (c) of this chapter.
    * * * * *
        3. Section 74.2101 is amended by revising paragraphs (b) and (c) to 
    read as follows:
    
    
    Sec. 74.2101  FD&C Blue No. 1.
    
    * * * * *
        (b) Specifications. (1) The color additive FD&C Blue No. 1 shall 
    conform in specifications to the requirements of Sec. 74.101(b).
        (2) FD&C Blue No. 1 Aluminum Lake shall be prepared in accordance 
    with the requirements of Sec. 82.51 of this chapter.
        (c) Uses and restrictions. (1) FD&C Blue No. 1 may be safely used 
    for coloring cosmetics generally, including cosmetics intended for use 
    in the area of the eye, in amounts consistent with current good 
    manufacturing practice.
        (2) FD&C Blue No. 1 Aluminum Lake may be safely used for coloring 
    cosmetics intended for use in the area of the eye, in amounts 
    consistent with current good manufacturing practice.
    * * * * *
    
        Dated: February 9, 1994.
    Michael R. Taylor,
    Deputy Commissioner for Policy.
    [FR Doc. 94-3554 Filed 2-15-94; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
2/17/1994
Published:
02/16/1994
Department:
Health and Human Services Department
Entry Type:
Uncategorized Document
Action:
Final rule.
Document Number:
94-3554
Dates:
Effective February 17, 1994, except as to any provisions that may be stayed by the filing of proper objections; written objections and requests for a hearing by March 18, 1994.
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: February 16, 1994, Docket No. 92C-0295
CFR: (4)
21 CFR 74.1101
21 CFR 74.2101
21 CFR 81.1
21 CFR 71.15